Kazutoshi Tobimatsu

Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial

Chigusa Morizane, Takuji Okusaka, Junki Mizusawa et al. · Annals of Oncology · 2019 · 320 citations

S-1 Versus Gemcitabine, Gastrointestinal Oncology, Medicine +7

Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system

Tomohiro Yamaguchi, Nozomu Machida, Chigusa Morizane et al. · Cancer Science · 2014 · 235 citations · Full text

Systemic Chemotherapy, Advanced Neuroendocrine Carcinoma, Gastroenterology +17

Dok1 mediates high-fat diet–induced adipocyte hypertrophy and obesity through modulation of PPAR-γ phosphorylation

Tetsuya Hosooka, Tetsuya Noguchi, Ko Kotani et al. · Nature Medicine · 2008 · 121 citations

Ppar-γ Phosphorylation, Metabolic Disorder, Adipokines +16

Randomized phase II study of chemoradiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group trial, JCOG1106

Tatsuya Ioka, Junji Furuse, Akira Fukutomi et al. · Japanese Journal of Clinical Oncology · 2020 · 31 citations · Full text

Muscle-Specific Overexpression of Heparin-Binding Epidermal Growth Factor-Like Growth Factor Increases Peripheral Glucose Disposal and Insulin Sensitivity

Yasuhide Fukatsu, Tetsuya Noguchi, Tetsuya Hosooka et al. · Endocrinology · 2009 · 27 citations · Full text

Glucose Tolerance, Insulin Signaling, Obesity +23